New inhibitor drug shows promise in preventing diabetic eye and kidney disease

New research has shown a new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease.

Canaan adds $100M+ to boost biopharma investing, brings on former Pfizer exec

Canaan, a decades-old tech and life sciences venture capital firm, plans to invest more heavily in biopharma going forward. The Menlo Park, CA-based firm added

April 18, 2024

Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31, 2024. – Biotech Investments

Spexis AG / Key word(s): Miscellaneous 30-Apr-2024 / 20:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely

May 1, 2024

20 years later: lessons from SARS-CoV-2 inform preparedness against future pandemics

The identification, development, and assessment of medical countermeasures against emerging pathogens.

June 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.